Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 28.30 INR
Change Today 0.00 / 0.00%
Volume 0.0
BFNA On Other Exchanges
Symbol
Exchange
BFNA is not on other exchanges.
As of 7:05 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

bafna pharmaceuticals ltd (BFNA) Snapshot

Open
28.30
Previous Close
28.30
Day High
29.50
Day Low
28.10
52 Week High
09/12/14 - 38.00
52 Week Low
02/10/15 - 23.50
Market Cap
528.0M
Average Volume 10 Days
290.7K
EPS TTM
3.57
Shares Outstanding
18.7M
EX-Date
09/19/13
P/E TM
7.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for BAFNA PHARMACEUTICALS LTD (BFNA)

Related News

No related news articles were found.

bafna pharmaceuticals ltd (BFNA) Related Businessweek News

No Related Businessweek News Found

bafna pharmaceuticals ltd (BFNA) Details

Bafna Pharmaceuticals Limited manufactures and sells medicines and drugs in India and internationally. The company offers Raricap for the treatment of iron deficiency anaemia; Raricap Forte for the treatment of iron deficiency anaemia in pregnancy and lactation; Raricap L Suspension for the treatment of iron deficiency anaemia in children; Raricap Combi for the treatment of iron deficiency anaemia and calcium deficiency during pregnancy and lactation; Raricap Drops for the treatment of iron deficiency and iron deficiency anaemia in infants and toddlers; Raricap M; and Raricap Maa. It also provides contract manufacturing services. The company was founded in 1981 and is based in Chennai, India.

Founded in 1981

bafna pharmaceuticals ltd (BFNA) Top Compensated Officers

Chairman, Managing Director, Member of Audit ...
Total Annual Compensation: 1.2M
Executive Director and Member of Stakeholders...
Total Annual Compensation: 960.0K
Compensation as of Fiscal Year 2014.

bafna pharmaceuticals ltd (BFNA) Key Developments

Bafna Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Bafna Pharmaceuticals Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported total income from operations (net) of INR 231.196 million compared to INR 352.265 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 9.882 million compared to INR 36.422 million a year ago. Loss from ordinary activates before tax was INR 11.183 million compared to profit from ordinary activates before tax of INR 4.200 million a year ago. Net loss was INR 11.927 million or INR 0.64 per basic and diluted share before and after extraordinary items (not annualized) compared to net profit of INR 3.094 million or INR 0.16 per basic and diluted share before and after extraordinary items (not annualized) a year ago.

Bafna Pharmaceuticals Limited to Report Q1, 2016 Results on Aug 12, 2015

Bafna Pharmaceuticals Limited announced that they will report Q1, 2016 results on Aug 12, 2015

Bafna Pharmaceuticals Limited, Board Meeting, Aug 12, 2015

Bafna Pharmaceuticals Limited, Board Meeting, Aug 12, 2015. Agenda: To consider the unaudited financial results for the quarter ended June 30, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BFNA:IN 28.30 INR 0.00

BFNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BFNA.
View Industry Companies
 

Industry Analysis

BFNA

Industry Average

Valuation BFNA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAFNA PHARMACEUTICALS LTD, please visit www.bafnapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.